93 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
at its sole discretion.
C. Employee shall be entitled to receive reimbursement for international tax services required as employee of Fennec up … awards in addition to the Equity Options described in 3(A).
4. Expense Reimbursement. Employee will be entitled to reimbursement from the Company
8-K/A
EX-10.1
FENC
Fennec Pharmaceuticals Inc
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
at its sole discretion.
C. Employee shall be entitled to receive reimbursement for international tax services required as employee of Fennec up … awards in addition to the Equity Options described in 3(A).
4. Expense Reimbursement. Employee will be entitled to reimbursement from the Company
424B5
FENC
Fennec Pharmaceuticals Inc
29 Apr 20
Prospectus supplement for primary offering
4:48pm
in reimbursement from Medicare or
S-15
other government programs may result in a similar reduction in payments from private payors. The implementation of cost … that we believe is fair for our products;
our ability to obtain coverage and reimbursement approval for a product;
our ability to generate revenues
424B5
FENC
Fennec Pharmaceuticals Inc
1 May 20
Prospectus supplement for primary offering
5:28pm
that we receive for any approved product. Any reduction in reimbursement from Medicare or
S-15
other government programs may result in a similar … and reimbursement approval for a product;
our ability to generate revenues and achieve or maintain profitability; and
the level of taxes that we are required
8-K
EX-10.1
sl5l7nx2
9 Sep 19
Fennec Appoints Shubh Goel As Chief Commercial Officer
4:13pm
20FR12B
EX-4.12
efavexu4bl21b0dp
17 Sep 04
Initial registration of securities (foreign private issuers)
12:00am
8-K
EX-10.1
75xlzs xrc93oyy1gd
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
424B3
o3t3hp9x9wjcjyu4zb7c
22 Jun 06
Prospectus supplement
12:00am
F-3
gqmwa
5 Jun 06
Shelf registration (foreign)
12:00am